Core Insights - The animal health sector experienced a rise of 1.97% on September 8, with Dayu Biological leading the gains [1] - The Shanghai Composite Index closed at 3826.84, up 0.38%, while the Shenzhen Component Index closed at 12666.84, up 0.61% [1] Group 1: Stock Performance - Dayu Biological (871970) closed at 11.20, with a gain of 9.27% and a trading volume of 176,500 shares, amounting to a transaction value of 202 million yuan [1] - Ruipu Biological (300119) closed at 22.39, up 3.51%, with a trading volume of 109,500 shares and a transaction value of 243 million yuan [1] - Kexin Biological (688526) closed at 18.59, gaining 3.28%, with a trading volume of 46,900 shares and a transaction value of 86.51 million yuan [1] - Yongshun Biological (839729) closed at 11.15, up 3.05%, with a trading volume of 77,600 shares and a transaction value of 87.23 million yuan [1] - Shenlian Biological (688098) closed at 12.10, gaining 2.89%, with a trading volume of 155,300 shares and a transaction value of 187 million yuan [1] Group 2: Capital Flow - The animal health sector saw a net inflow of 63.35 million yuan from institutional investors, while retail investors experienced a net outflow of 61.99 million yuan [2] - The main capital flow data indicates that Ruipu Biological had a net outflow of 30.35 million yuan from institutional investors, while Shenlian Biological had a net inflow of 30.09 million yuan [3] - Overall, the sector's capital flow reflects a mixed sentiment, with some stocks attracting institutional interest while others faced retail selling pressure [3]
动物保健板块9月8日涨1.97%，大禹生物领涨，主力资金净流入6335.09万元